Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

In the year 2023, Verrica Pharmaceuticals had annual revenue of $5.12M, a decrease of -43.27%. Revenue in the quarter ending December 31, 2023 was $1.99M with 2,823.53% year-over-year growth.

• Revenue (ttm): $5.12M
• Revenue Growth: -43.27%
• P/S Ratio: 59.19
• Revenue / Employee: $51,240
• Employees: 100
• Market Cap: 302.03M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.